About Robert Taglich
Robert Taglich is a 10% owner at Intellinetics.
Form D filings name Robert Taglich as a director at Dilon Technologies and BioVentrix.
Robert Taglich reports to the SEC as a director or major shareholder of 4 public companies, including Air Industries Group (AIRI), Icagen and Bridgeline Digital (BLIN).
Robert Taglich first appears on SEC filings in 2008.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Taglich in the role, so the role may have started earlier or lasted longer.
II
Intellinetics, Inc.
10% owner
2015 – 2026 · Public company (INLX)
Dilon Technologies Inc.
Director
2025 – 2026 · Newport News, VA
Dilon makes medical devices for healthcare providers, including tools for breast cancer surgery.
AG
Air Industries Group
Director and 10% owner
2008 – 2026 · Public company (AIRI)
Bioventrix, Inc.
Director
2013 – 2020 · Mansfield, MA
Develops an investigational heart device for surgeons treating patients with heart failure.
II
Icagen, Inc.
Director and 10% owner
2017 – 2019 · Public company
BI
Bridgeline Digital, Inc.
Director
2016 – 2017 · Public company (BLIN)
Key Colleagues at Startups
The people Robert Taglich works with at each company, as listed on that company's latest Form D.
Dilon Technologies Inc. · Form D/A, Mar 11, 2026
RM
Robert Moussa
Director
RB
Rachel Brem
Director
FB
Francis Bissaillon
Director
MT
Michael Taglich
Director
TJ
Tim Jette
Executive officer
GM
George Makhoul
CEO and director
Bioventrix, Inc. · Form D, Jan 6, 2020
PS
Paul Seid
Director
WI
Warren Pinkert II
Director
GF
George Fazio
Director
MR
Mark Ravich
Independent Board Member
WA
William Abbott
Executive officer
KM
Kenneth Miller
Chief Executive Officer and director
MT
Michael Taglich
Director
SH
Stephen Healy
Director